Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Withdrawn 2 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1 CNS 1

Conditions

Interventions

Temozolomide 80 Radiotherapy 41 Bevacizumab 35 Radiosurgery 23 Magnetic Resonance Spectroscopy 20 Cyclophosphamide 17 Radiation 14 Irinotecan 13 Carboplatin 12 Topotecan 11 Nivolumab 11 Lomustine 11 Filgrastim 10 Everolimus 10 Etoposide 10 Erlotinib Hydrochloride 10 pembrolizumab 9 Radiotherapy, Intensity-Modulated 9 Ipilimumab 9 Granulocyte Colony-Stimulating Factor 8 Carmustine 8 antineoplaston AS 2-1 7 antineoplaston A10 7 Surgical Procedures, Operative 7 Mental Status and Dementia Tests 7 Isotretinoin 7 Granulocyte-Macrophage Colony-Stimulating Factor 7 sargramostim 6 Vincristine 6 TPI-287 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × irinotecan sucrosofate × CNS × Clear all

NCT03119064 2022-12-13

329

Brown University

Phase 1/2 Terminated

12 enrolled 13 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡